“Understanding the impact of COVID-19 by demographic group is critical to ensure equity in our response to this virus,” the governor said. “We must do everything we can to protect the most vulnerable groups in our state during this unprecedented crisis. This data will inform our efforts and allow us to make sure that no one is left behind.”

Laboratory capacity is expected to expand from approximately 70,000 per day by the end of this week to approximately 150,000 a day by early-May.

A request for Emergency Use Authorization is under review by the U.S. Food and Drug Administration; if approved the medical manufacturer expects the test to be available for customers in early May 2020.

Morris Plains-based Immunomedics, Inc. a biopharmaceutical company specializing in antibody-drug conjugates (ADC), announced Wednesday that the U.S. Food and Drug Administration has approved Trodelv (sacituzumab govitecan-hziy) for the treatment of adult patients with metastatic triple-negative breast cancer (TNBC) who have received at least two prior therapies for metastatic disease. Trodelvy is the first ADC approved by the FDA specifically for relapsed ...

While health care professionals worldwide are facing shortages of personal protection equipment (PPE), students and staff from across Rutgers are coming together to produce face shields and intubation boxes themselves with off-the-shelf materials to help relieve the PPE shortage at area hospitals. In the largest university-wide initiative to protect frontline hospital workers, the RU 3D PPE project is bringing together ...

Indiana-based Elanco Animal Health Incorporated announced Tuesday that it will expand its existing leadership team, adding a chief marketing officer and three commercial leaders to its current executive committee. The expanded team adds depth and experience to position Elanco for continued growth. “With our anticipated addition of Bayer Animal Health, we’re looking to ensure we have the right structure and ...

The study includes a series of clinical trials that will explore new drug treatments, antibody testing, and long-term health tracking in the hope of providing insight into how to treat the disease and prevent its spread.

Bergen New Bridge Medical Center said Tuesday that it would begin using the NanoVaporBiotech Microbial Suppression System as an initiative to contain and mitigate the impact of COVID-19. The system facilitates the disinfecting and suppression of microbials, such as coronaviruses, by spraying surfaces with a product that removes and suppresses through a nano-coating. It inhibits the growth of microorganisms and ...

East Hanover-based Novartis announced Monday that it completed the acquisition of Amblyotech, a U.S.-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia. Designed to enhance compliance, Amblyotech utilizes active gaming and passive video technology with 3-D glasses, training the eyes to work together to ...

Department of Health surveyors were out in force visiting long term care facilities to inspect and assess their compliance with state and federal regulations and guidelines.

The new vice president and general manager comes to NJII from Bergen New Bridge Medical Center.

The team said they are the first in the state to receive FDA approval for the procedure.